Compare NSRX & DFNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSRX | DFNS |
|---|---|---|
| Founded | 2019 | 2013 |
| Country | Israel | United States |
| Employees | 7 | 15 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 27.2M |
| IPO Year | N/A | N/A |
| Metric | NSRX | DFNS |
|---|---|---|
| Price | $2.25 | $0.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.67 | N/A |
| AVG Volume (30 Days) | 176.1K | ★ 1.2M |
| Earning Date | 03-25-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.98 | $0.42 |
| 52 Week High | $9.99 | $2.68 |
| Indicator | NSRX | DFNS |
|---|---|---|
| Relative Strength Index (RSI) | 36.03 | 27.80 |
| Support Level | $1.98 | $0.42 |
| Resistance Level | $5.20 | $2.44 |
| Average True Range (ATR) | 0.22 | 0.11 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 40.85 | 32.56 |
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
T3 Defense Inc is a holding company that acquires and operates mission-critical defense businesses involved in national security programs. It focuses on manufacturers with tough customer relationships and solid order backlogs, often capacity-and resource-constrained and specialized areas such as drones and autonomous vehicles, counter-drone systems, main manufacturing, tactical robotics, and AI software and system integration. Through disciplined acquisitions, centralized capital and ideas, and decentralized day-to-day operations, it aims to strengthen essential defense capabilities and build long-term value.